» Articles » PMID: 18094985

HPV Status and Regional Metastasis in the Prognosis of Oral and Oropharyngeal Cancer

Overview
Date 2007 Dec 21
PMID 18094985
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Prognostic factors are important for treatment decisions as they help adapt the therapy on a case-to-case basis. Nodal status, number of positive nodes, and presence of extracapsular spread are considered to be the important prognostic factors in head and neck cancer. Some studies suggest that human papillomavirus (HPV) status also influences the outcome of the treatment. This influence can be explained by the variation in tendency to develop regional metastases and by variation in the type of neck node involvement. The study objectives were to compare patients with HPV positive and HPV-negative tumors for survival and prevalence and type of regional metastasis, to identify prognostic factors and to test whether HPV presence is an independent factor of survival. The study included 81 patients treated by surgery including neck dissection for oral or oropharyngeal squamous cell cancer. A computerized medical report was completed for each patient. Analysis of the tumor specimen for the HPV DNA presence was done on paraffin-fixed tissue. HPV DNA detection and typing were performed by PCR with GP5+/GP6+BIO primers and reverse line blot hybridization. Overall, 64% (52/81) of tumors were HPV positive with 80% in the tonsillar site. HPV-positive patients had significantly better both overall (73 vs. 35%) (P=0.0112) and disease-specific (79 vs. 45%) (P=0.0015) survival rates than HPV-negative patients. No significant differences were found in the pN classification, in the number of positive nodes and the presence of extracapsular spread in the involved nodes between HPV positive and HPV-negative tumors. Multivariate analysis showed that significant prognostic factors of survival were the presence of HPV in the tumor, extracapsular spread and tumor size. HPV was the most significant prognostic factor in the studied group of patients with oropharyngeal tumors (HR=0.27, 95%CI 0.12-0.61) and possibly should be considered in treatment decisions.

Citing Articles

HPV-driven cancer: from epidemiology to the HPV-driven tumor board proposal, everything you wanted to know but were afraid to ask.

Alterio D, Gola M, Zaffaroni M, Vincini M, Cattaneo C, Aristei C Clin Transl Oncol. 2025; .

PMID: 40048019 DOI: 10.1007/s12094-025-03868-3.


High-Risk Human Papillomavirus in Patients with Oral Carcinoma and Oral Potentially Malignant Disorders in Serbia-A Pilot Study.

Petrovic A, cankovic M, Avramov M, Popovic Z, Jankovic S, Mojsilovic S Medicina (Kaunas). 2023; 59(10).

PMID: 37893561 PMC: 10608774. DOI: 10.3390/medicina59101843.


Assessment of awareness of human papillomavirus infection impact on oral cavity among patients.

Oleszkiewicz-Spiolek J, Adamska P, Marvaso G, Jereczek-Fossa B, Wychowanski P, Starzynska A Postepy Dermatol Alergol. 2022; 38(6):985-993.

PMID: 35126005 PMC: 8802954. DOI: 10.5114/ada.2020.97396.


Detection of HPV infection in head and neck cancers: Promise and pitfalls in the last ten years: A meta-analysis.

Gotz C, Bischof C, Wolff K, Kolk A Mol Clin Oncol. 2019; 10(1):17-28.

PMID: 30655973 PMC: 6313947. DOI: 10.3892/mco.2018.1749.


Evaluation of the Prevalence Rate and the Prognostic Effect of Human Papilloma Virus Infection in a Group of Patients With Oral Cavity Squamous Cell Carcinoma.

Saghravanian N, Zamanzadeh M, Meshkat Z, Aghaee M, Salek R Iran J Cancer Prev. 2016; 9(3):e3998.

PMID: 27703640 PMC: 5038837. DOI: 10.17795/ijcp-3998.


References
1.
Schwartz S, Yueh B, McDougall J, Daling J, Schwartz S . Human papillomavirus infection and survival in oral squamous cell cancer: a population-based study. Otolaryngol Head Neck Surg. 2001; 125(1):1-9. DOI: 10.1067/mhn.2001.116979. View

2.
Strome S, Savva A, Brissett A, Gostout B, Lewis J, Clayton A . Squamous cell carcinoma of the tonsils: a molecular analysis of HPV associations. Clin Cancer Res. 2002; 8(4):1093-100. View

3.
Koskinen W, Chen R, Leivo I, Makitie A, Back L, Kontio R . Prevalence and physical status of human papillomavirus in squamous cell carcinomas of the head and neck. Int J Cancer. 2003; 107(3):401-6. DOI: 10.1002/ijc.11381. View

4.
Klussmann J, Weissenborn S, Wieland U, Dries V, Eckel H, Pfister H . Human papillomavirus-positive tonsillar carcinomas: a different tumor entity?. Med Microbiol Immunol. 2003; 192(3):129-32. DOI: 10.1007/s00430-002-0126-1. View

5.
Dahlstrom K, Adler-Storthz K, Etzel C, Liu Z, Dillon L, El-Naggar A . Human papillomavirus type 16 infection and squamous cell carcinoma of the head and neck in never-smokers: a matched pair analysis. Clin Cancer Res. 2003; 9(7):2620-6. View